increased mammary adenocarcinoma incidence_Tg(MMTV-KRAS*G12V)3025Mrl/0

http://metadb.riken.jp/0001883IC57BL6FVBSJLTgMMTVKRASG12V3025Mrl0TgMMTVKRASG12V3025Mrl

increased mammary adenocarcinoma incidence_Tg(MMTV-KRAS*G12V)3025Mrl/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 3025, Merck Research Laboratory
  http://metadb.riken.jp/db/mgi_rdf/MGI:5827743

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(MMTV-KRAS*G12V)3025Mrl/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(MMTV-KRAS*G12V)3025Mrl

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6 * FVB * SJL

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased mammary adenocarcinoma incidence
  http://purl.obolibrary.org/obo/MP_0001883

文献

http://purl.org/net/cito/citesAsAuthority

• C A. Omer, et.al., Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor., Cancer research, 2000, 60
  http://rdf.ncbi.nlm.nih.gov/pubmed/10825141